Ann: March 2019 Quarterly Operational Update and App4C, page-29

First 29 Last

Share
Profile

Follow
travelbug2

6,832 Posts.

383

30/05/19

12:55

Post #: 38823853
Share

Originally posted by travelbug2: ↑

from the Q report above

"We have approximately 40 second generation CPPs to test during Q2 before identifying apreferred ‘lead’ candidate/s. The lead candidates will be optimised for drug-like properties andundergo testing in larger animals (both efficacy and toxicity evaluation) before progressing tothe clinic.Phylogica will hold an investor morning to provide shareholders with an update on theevaluation of our second generation CPP candidates in the animal models described above inJune. Further details will be provided closer to the date."

So pretty soon they will have some idea how this is all going. Next announcement sounds like a date to look see. I am not in a position to go, hopefully others are. Identifying the lead candidates will also probably lead to an announcement, and a statement about how good they are.

Fingers crossed. Buy list looks a lot better than a few weeks back. Lets hope it continues.

Expand

a recent deal in our space. Lets hope we can get somewhere like this in the not too distant future
https://www.fiercebiotech.com/biotech/stoke-files-for-86m-ipo-to-take-dravet-drug-from-preclinical-to-phase-3

PYC Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

First 29 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.29		Change 0.000(0.00%)		Mkt cap ! $746.5M

Open	High	Low	Value	Volume
$1.29	$1.29	$1.28	$4.538M	3.587M

Buyers (Bids)

No.	Vol.	Price($)
2	25835	$1.26

Sellers (Offers)

Price($)	Vol.	No.
$1.29	67599	4

View Market Depth

No.	Vol.	Price($)
2	25835	1.255
1	19982	1.250
2	4225	1.225
1	20000	1.220
1	4000	1.200

Price($)	Vol.	No.
1.285	67637	4
1.295	24501	2
1.300	28670	3
1.325	9001	1
1.330	20756	3

Last trade - 12.22pm 26/06/2025 (20 minute delay)

PYC (ASX) Chart

Ann: March 2019 Quarterly Operational Update and App4C, page-29

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: March 2019 Quarterly Operational Update and App4C, page-29

Top Stories

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News